Rare diseases
Investigational molecules
Locations
Back to Portugal648 clinical trials in Lisbon, Portugal across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease
PortugalPhase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
PortugalSafety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1
PortugalStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
PortugalEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
PortugalStudy of subcutaneous anifrolumab pharmacokinetics, pharmacodynamics and safety in children aged 5 to <18 years with systemic lupus erythematosus
PortugalStudy of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy
PortugalEfficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study
PortugalEfficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)
PortugalEpcoritamab plus rituximab versus rituximab alone in elderly, frail or unfit patients with newly diagnosed diffuse large B‑cell lymphoma
PortugalSafety and Efficacy of Intrathecal BIIB115 in Infants with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec
PortugalEfficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancer treatments and advanced lung cancer therapies, combining novel approaches with standard treatments.
Studies evaluate targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into various autoimmune disorders, with particular focus on psoriasis and systemic sclerosis treatments.
Testing innovative biological therapies and novel treatment approaches.
Studies examining treatments for Dravet Syndrome and Alzheimer's-related psychosis, focusing on improving patient quality of life.
Investigating new therapeutic options for challenging neurological conditions.
Research targeting Crohn's Disease and various inflammatory conditions, evaluating new treatment combinations.
Testing advanced therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
